The future of healthcare is defined by this blend of technology and human expertise, offering new hope for a more efficient ...

Bayer seeks Japanese marketing approval for finerenone to treat adult patients with chronic heart failure: Berlin Saturday, February 15, 2025, 14:00 Hrs [IST] Bayer announced the ...

Learn how chronic kidney disease and diabetes accelerate heart risk, with new research revealing early warning signs.

Without the appropriate CKD assessment, timely treatment with neuroprotective medicines increasingly recognized as the pillars of CKD therapy — angiotensin-converting enzyme (ACE) inhibitors ...

The chronic kidney disease drug development landscape is evolving at an unprecedented pace, driven by breakthrough approvals, billion-dollar mergers and acquisitions, and increasing regulatory support ...

Researchers at the University of Pennsylvania's Perelman School of Medicine have identified over 1,000 genes that could serve ...

"Providing access to quality care for our Medicare Advantage members with complex health conditions is crucial," said Alan Stewart, President of Humana's Medicare East Division. "Our collaboration ...

AI-based HelloKidney.ai, developed by Indian nephrologist Dr. Chinta Rama Krishna, is effective in early detection and ...

He loves ball hockey and ice hockey to his core. He is a team player and likes to be there for everybody,' says mother of ...

Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD), obstructive sleep apnea ...

In a significant step towards addressing public health challenges, the Health Department constituted a dedicated task force ...